🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00704R109
- IPO
- 9/29/2023 · $23/share
- ADR Ratio
- 1:3
Business: Adlai Nortye Ltd. is a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types, with our multi-national R&D centers established in New Jersey and Hangzhou.
Company Contact
- CEO
- Yang (Carsten) Lu
- CFO
- Xiaofeng (Alex) Ye
- Investor Relations
- ir@adlainortye.com